Come up with a name for your new list and we'll add to it:
Ceptaris Therapeutics raised a round of funding on March 13, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Ceptaris Therapeutics, formerly Yaupon Therapeutics, is developing a gel formulation of mechlorethamine hydrochloride (mechlorethamine) for the treatment of early stage (stages I-IIA) mycosis fungoide…